Dade Behring Marburg Gmbh

Behringwerke Aktiengesellschaft

Lazare Kaptue

Hans-Peter Hauser

Stefan Knapp

Stefan Brust

Josef Eberle

Lutz G Gurtler

Lutz G Guertler

Léopold Achenqui Zekeng

Lutz G Gürtler

Leopold Zekeng

Yvette Beatrice Dongmo Deloko

Hans Peter Hauser

Lutz G G&uuml;rtler

L&eacute;opold Achengui Zekeng

Leopold Achengui Zekeng

A novel HIV type O immunodeficiency virus is disclosed which has the designation MVP-2901/94 and which has been deposited with the European collection of animal Cell Cultures (ECACC) under No. V 950121601. The characteristic antigens which can be obtained from the virus and which can be employed for detecting antibodies against retroviruses which are associated with immunodeficiency diseases are also disclosed, as are the partial DNA and amino acid sequences of the virus.

Retrovirus from the HIV type O and its use (MVP-2901/94)

The present invention relates to an immunodeficiency virus of drill monkeys, its RNA, the corresponding cDNA, proteins derived therefrom and fragments of the nucleic acids or proteins. The invention likewise relates to the diagnostic use of the nucleic acids and proteins mentioned and their fragments and to a diagnostic.

Lentivirus from the group of immunodeficiency viruses of drill monkeys (Mandrillus leucophaeus) and their use

A novel HIV type O immunodeficiency virus is disclosed which has the designation MVP-2901/94 and which has been deposited with the European Collection of Animal Cell Cultures (ECACC) under No. V 950121601. The characteristic antigens which can be obtained from the virus and which can be employed for detecting antibodies against retroviruses which are associated with immunodeficiency diseases are also disclosed, as are the partial DNA and amino acid sequences of the virus.

A novel immunodeficiency virus is disclosed which has the designation MVP-2901/94 and which has been deposited with the European Collection of Animal Cell Cultures (ECACC) under No. V 95012601. The characteristic antigens which can be obtained from the virus and which can be employed for detecting antibodies against retroviruses which are associated with immunodeficiency diseases are also disclosed, as are the partial DNA and amino acid sequences of the virus.

Retrovirus from the HIV group and its use (MVP-2901/94)

A novel HIV type O immunodeficiency virus is disclosed which has the designation MVP-2901/94 and which has been deposited with the European Collection of Animal Cell Cultures (ECACC) under No. V 95012601. The characteristic antigens which can be obtained from the virus and which can be employed for detecting antibodies against retroviruses which are associated with immunodeficiency diseases are also disclosed, as are the partial DNA and amino acid sequences of the virus.

Growing community of inventors

Yaoundé/Cameroun, Germany

Lazare Kaptue